Modification of a tumor antigen determinant to improve peptide/MHC stability is associated with increased immunogenicity and cross-priming a larger fraction of CD8+ T cells
Alan M. Watson, Lawrence M. Mylin, Megan M. Thompson, Todd D. Schell
Dive into the research topics of 'Modification of a tumor antigen determinant to improve peptide/MHC stability is associated with increased immunogenicity and cross-priming a larger fraction of CD8+ T cells'. Together they form a unique fingerprint.